 |
Human monoclonal antibody inhibitor of mannan-binding lectin-associated serine protease-2 (MASP-2) |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention (inhibition) of complement-mediated thrombotic microangiopathy |
| USA Market Approval | USA |
| USA Designation Date | 2013-12-16 00:00:00 |
| Sponsor | Omeros Corporation;201 Elliott Avenue West;Seattle, Washington, 98119 |
